Article Details
Retrieved on: 2024-07-10 22:02:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Analyst Douglas Tsao of H.C. Wainwright reiterated a Buy rating on AEON Biopharma (AEON – Research Report), retaining the price target of ...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here